L. H. Beck, R. G. Bonegio, and G. Lambeau, M-type phospholipase A2 receptor as target antigen in idiopathic MN, N Engl J Med, vol.361, pp.11-21, 2009.

P. Ronco and H. Debiec, Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, The Lancet, vol.385, pp.1983-92, 2015.

R. Stahl, E. Hoxha, and K. Fechner, PLA2R1 autoantibodies and recurrent membranous nephropathy after transplantation, N Engl J Med, vol.363, pp.496-504, 2010.

A. Grupper, L. D. Cornell, F. C. Fervenza, L. H. Beck, E. Lorenz et al., Recurrent Membranous nephropathy after kidney transplantation: Treatment and long-term implications, Transplantation, vol.100, pp.2710-2716, 2016.

J. Leon, M. J. Pérez-sáez, and I. Batal, Membranous Nephropathy Post-Transplantation: An Update of the Pathophysiology and Management, Transplantation, vol.103, pp.1990-2002, 2019.

Z. M. El-zoghby, J. P. Grande, M. G. Fraile, S. M. Norby, F. C. Fervenza et al., Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies, Am J Transplant, vol.9, pp.2800-2807, 2009.

M. B. Andrésdóttir and J. F. Wetzels, Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation, Am J Transplant, vol.12, pp.265-271, 2012.

A. L. Kennard, S. H. Jiang, and G. D. Walters, Increased glomerulonephritis recurrence after living related donation, BMCNephrol, vol.18, p.25, 2017.

L. F. Quintana, M. Blasco, and M. Seras, Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy, Transplantation, vol.99, pp.1709-1723, 2015.

F. G. Cosio and D. C. Cattran, Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation, Kidney Int, vol.91, pp.304-314, 2017.

A. Kattah, R. Ayalon, L. H. Beck, and . Jr, Anti-phospholipase A? receptor antibodies in recurrent membranous nephropathy, Am J Transplant, vol.15, pp.1349-59, 2015.

H. Debiec, L. Martin, and C. Jouanneau, Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy, Am J Transplant, vol.11, pp.2144-52, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00919176

N. M. Tomas, L. H. Beck, and C. Meyer-schwesinger, Thrombospondin type-1 domaincontaining 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-87, 2014.

H. C. Stanescu, M. Arcos-burgos, and A. Medlar, Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, pp.616-642, 2011.

S. Gupta, A. Köttgen, and E. Hoxha, Genetics of membranous nephropathy, Nephrol Dial Transplant, vol.33, pp.1493-1502, 2018.

J. Xie, L. Liu, and N. Mladkova, The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, Nat Commun, vol.11, issue.1, p.1600, 2020.

J. Lv, W. Hou, and X. Zhou, Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R1 antibodies and membranous nephropathy, J Am SocNephrol, vol.24, pp.1323-1332, 2013.

D. Kanigicherla, J. Gummadova, and E. A. Mckenzie, Anti-PLA2R1 antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy, Kidney Int, vol.83, pp.940-948, 2013.

W. B. Le, J. S. Shi, and T. Zhang, HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R1-Related Membranous Nephropathy, J Am Soc, vol.28, pp.1642-50, 2017.

Z. Cui, L. J. Xie, and F. J. Chen, MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy, J Am Soc Nephrol, vol.28, pp.1651-64, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02193804

F. Pourcine, K. Dahan, and F. Mihout, Prognostic value of PLA2R1 autoimmunity detected by measurement of anti-PLA2R1 antibodies combined with detection of PLA2R1 antigen in membranous nephropathy: A single-centre study over 14 years, PLoS One, vol.12, p.173201, 2017.

P. Sekula, Y. Li, H. C. Stanescu, and M. Wuttke, Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies

, Nephrol Dial Transplant, vol.32, pp.325-357, 2017.

S. Kim, H. J. Chin, and K. Y. Na, Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy, Nephron Clin Pract, vol.117, pp.253-261, 2011.

M. Thiri, K. Honda, and K. Kashiwase, High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese, Sci Rep, vol.6, p.38189, 2016.

C. Qiu, S. Huang, and J. Park, Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease, Nat Med, vol.24, pp.1721-1752, 2018.

E. Kuang, C. Y. Okumura, and S. Sheffy-levin, Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and influences susceptibility to bacterial infection, PLoS Genet, vol.8, p.1003007, 2012.

M. Beeken, M. T. Lindenmeyer, and S. M. Blattner, Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuricdiseases, J Am SocNephrol, vol.25, pp.2511-2536, 2014.

A. Goldwich, M. Burkard, and M. Ölke, Podocytes Are Nonhematopoietic Professional Antigen-Presenting Cells, J Am Soc Nephrol, vol.24, pp.906-922, 2013.

W. Jiang, W. J. Swiggard, and C. Heufler, The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing, Nature, vol.375, pp.151-156, 1995.

I. Batal, E. R. Vasilescu, and D. M. Dadhania, Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series, Am J Kidney Dis, issue.20, pp.900-1436, 2020.

, **11-20 missing values

, ***21 -30 missing values

, §31-40 missing values; eGFR (estimated Glomerular Filtration Rate) was calculated according to the Chronic Kidney Disease Epidemiology Collaboration equation

, §Among the 45 recurrent patients, 12 received a transplant between 2011 and 2015: 4 were tested at transplantation (all positive), 5 were tested after (all positive), 3 have not been tested. Among the 60 non-recurrent patients, 16 received a transplant between 2011 and 2015: 5 were tested at transplantation (all negative), 1was tested after (negative), 10 have not been tested